M. Kraaij

First do no harm: iron loss in whole blood donors

M. Sweegers, M. Kraaij, K. Hurk, 2020, ISBT Science Series.

Lessons from the INTERVAL study

M. Kraaij, K. Hurk, S. Zalpuri, 2018, The Lancet.

Immunocompromised Adults Syncytial Virus Infection in PCR Assay for Diagnosis of Respiratory Applicability of a Real-Time Quantitative

P., M. Nijhuis, A. Hoepelman, 2003 .

Elevated Labile Plasma Iron Levels (LPI) and Increased Oxidative Stress Are Associated with Red Blood Cell Transfusions in Patients with Lower-Risk Myelodysplastic Syndromes (MDS) Subtitle: from the European Leukemianet MDS Registry

Alexandra G. Smith, D. Swinkels, H. Garelius, 2016 .

Emergence and infectious complications of ciprofloxacin-resistantEscherichia coli in haematological cancer patients

A. Fluit, M. Kraaij, L. Verdonck, 1998, European Journal of Clinical Microbiology and Infectious Diseases.

How we manage patients with hereditary haemochromatosis

G. Koek, M. Kraaij, E. Rombout-Sestrienkova, 2016, British journal of haematology.

RBC Adhesive Capacity Is Essential for Efficient 'Immune Adherence Clearance' and Provide a Generic Target to Deplete Pathogens from Septic Patients

T. Kuijpers, N. Juffermans, E. Kostova, 2016 .

Thirteen novel mutations in the factor VIII gene in the Nijmegen haemophilia A patient population

W. Heerde, B. Verbruggen, P. Brons, 2005, British journal of haematology.

Iron deficiency–related symptoms in whole blood donors: a systematic review

K. van den Hurk, M. Kraaij, K. Hurk, 2019, Transfusion.